Organon & annual r&d spending
2019
2020
2021
2022
2023
2024
2025
Organon & R&D Spending Growth & History (OGN)
Organon &'s r&d spending was $366.0M for fiscal 2025.
View full Organon & company overviewOrganon & annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $366.0M | −$103.0M | −21.96% |
| 2024 | 2024-12-31 | $469.0M | −$59.0M | −11.17% |
| 2023 | 2023-12-31 | $528.0M | $57.0M | +12.10% |
| 2022 | 2022-12-31 | $471.0M | $132.0M | +38.94% |
| 2021 | 2021-12-31 | $339.0M | $129.0M | +61.43% |
| 2020 | 2020-12-31 | $210.0M | −$10.0M | −4.55% |
| 2019 | 2019-12-31 | $220.0M | — | — |
Organon & quarterly r&d spending
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $90.0M | −$5.0M | −5.26% |
| Q1 2026 | 2026-03-31 | $93.0M | −$3.0M | −3.13% |
| Q4 2025 | 2025-12-31 | $91.0M | −$39.0M | −30.00% |
| Q3 2025 | 2025-09-30 | $84.0M | −$27.0M | −24.32% |
| Q2 2025 | 2025-06-30 | $95.0M | −$21.0M | −18.10% |
| Q1 2025 | 2025-03-31 | $96.0M | −$16.0M | −14.29% |
| Q4 2024 | 2024-12-31 | $130.0M | −$4.0M | −2.99% |
| Q3 2024 | 2024-09-30 | $111.0M | −$26.0M | −18.98% |
| Q2 2024 | 2024-06-30 | $116.0M | −$12.0M | −9.38% |
| Q1 2024 | 2024-03-31 | $112.0M | −$17.0M | −13.18% |
| Q4 2023 | 2023-12-31 | $134.0M | −$8.0M | −5.63% |
| Q3 2023 | 2023-09-30 | $137.0M | $10.0M | +7.87% |
| Q2 2023 | 2023-06-30 | $128.0M | $22.0M | +20.75% |
| Q1 2023 | 2023-03-31 | $129.0M | $33.0M | +34.38% |
| Q4 2022 | 2022-12-31 | $142.0M | — | — |
| Q3 2022 | 2022-09-30 | $127.0M | $41.0M | +47.67% |
| Q2 2022 | 2022-06-30 | $106.0M | $30.0M | +39.47% |
| Q1 2022 | 2022-03-31 | $96.0M | $29.0M | +43.28% |
| Q3 2021 | 2021-09-30 | $86.0M | $32.0M | +59.26% |
| Q2 2021 · Jun 30 | 2021-06-30 | $76.0M | $25.0M | +49.02% |
| Q1 2021 | 2021-03-31 | $67.0M | $22.0M | +48.89% |
| Q4 2020 | 2020-12-31 | $60.0M | — | — |
| Q3 2020 | 2020-09-30 | $54.0M | — | — |
| Q2 2020 | 2020-06-30 | $51.0M | — | — |
| Q1 2020 | 2020-03-31 | $45.0M | — | — |
Organon & r&d spending trends
Over the last five fiscal years, Organon &'s r&d spending increased from $210.0M to $366.0M, a change of $156.0M. The latest reported quarter, Q2 2026, shows $90.0M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Organon & source filings ↗